Renin levels and cardiovascular morbidity: a prospective study of the effect of beta-adrenergic blocking drugs

Reference

• Agabiti Rosei E., Brown J. J., Cumming A. M. M., Fraser R., Semple P. F., Lever A. F., Morton J. J., Robertson A. S., Robertson J. I. S., Tree M. Is the ‘sodium index’ a useful way of expressing clinical plasma renin, angiotensin and aldosterone values?. Clin. Endocrinol. 1978; 8: 1411. Agabiti Rosei E., Brown J. J., Cumming A. M. M., Fraser R., Semple P. F., Lever A. F., Morton J. J., Robertson A. S., Robertson J. I. S., Tree M. Is the ‘sodium index’ a useful way of expressing clinical plasma renin, angiotensin and aldosterone values?. Clin. Endocrinol. 1978; 8: 141
   PubMed Web of Science ®Google Scholar
• Ahlmark G., Saetre H., Korsgren M. Reduction of sudden deaths after myocardial infarction. Lancet 1974; 2: 15632. Ahlmark G., Saetre H., Korsgren M. Reduction of sudden deaths after myocardial infarction. Lancet 1974; 2: 1563
   PubMed Web of Science ®Google Scholar
• BirkenhÄGer W. H., Kho T. L., Schalekamp M. A. D. H., Kolstens G., Wester A., De Leeuw P. W. Renin levels and cardiovascular morbidity in essential hypertension. Acta Clin. Belg. 1977; 32: 1683. BirkenhÄGer W. H., Kho T. L., Schalekamp M. A. D. H., Kolstens G., Wester A., De Leeuw P. W. Renin levels and cardiovascular morbidity in essential hypertension. Acta Clin. Belg. 1977; 32: 168
   PubMed Web of Science ®Google Scholar
• Brunner H. R., BÜHler F. R., Baer L., Laragh J. H. Renin and aldosterone in etiology and prognosis of ‘essential’ hypertension. Circulation 1971; 43/44: 121a, Suppl. 24. Brunner H. R., BÜHler F. R., Baer L., Laragh J. H. Renin and aldosterone in etiology and prognosis of ‘essential’ hypertension. Circulation 1971; 43/44: 121a, Suppl. 2
   Web of Science ®Google Scholar
• Brunner H. R., Laragh J. H., Baer L., Newton F. A., Goodwin F. T., Krakoff L. R., Bard H. R., BÜHler F. R. Essential hypertension: renin and aldosterone, heart attack and stroke. N. Engl. J. Med. 1972; 286: 4415. Brunner H. R., Laragh J. H., Baer L., Newton F. A., Goodwin F. T., Krakoff L. R., Bard H. R., BÜHler F. R. Essential hypertension: renin and aldosterone, heart attack and stroke. N. Engl. J. Med. 1972; 286: 441
   PubMed Web of Science ®Google Scholar
• Brunner H. R., Sealey J. E., Laragh J. H. Renin as a risk factor in essential hypertion: more evidence. Am. J. Med. 1973; 55: 2956. Brunner H. R., Sealey J. E., Laragh J. H. Renin as a risk factor in essential hypertion: more evidence. Am. J. Med. 1973; 55: 295
   PubMed Web of Science ®Google Scholar
• Christlieb A. R., Gleason R. E., Hickler R. B., Lauler D. P. Renin: a risk factor for cardiovascular disease. Ann. Int. Med. 1974; 81: 77. Christlieb A. R., Gleason R. E., Hickler R. B., Lauler D. P. Renin: a risk factor for cardiovascular disease. Ann. Int. Med. 1974; 81: 7
   PubMed Web of Science ®Google Scholar
• Doyle A. E., Jerums G., Johnston C. I., Louis W. I. Plasma renin levels and vascular complications in hypertension. Br. Med. J. 1973; 2: 2068. Doyle A. E., Jerums G., Johnston C. I., Louis W. I. Plasma renin levels and vascular complications in hypertension. Br. Med. J. 1973; 2: 206
   PubMed Web of Science ®Google Scholar
• Fox K. M., Chopra M. P., Portal R. W., Aber C. P. Long-term beta blockade: possible protection from myocardial infarction. Br. Med. J. 1975; 1: 1179. Fox K. M., Chopra M. P., Portal R. W., Aber C. P. Long-term beta blockade: possible protection from myocardial infarction. Br. Med. J. 1975; 1: 117
   PubMed Web of Science ®Google Scholar
• Genest J., Boucher R., Kuchel O., Nowaczynski W. Renin in hypertension: how important as a risk factor?. Can. Med. Assoc. J. 1975; 109: 47510. Genest J., Boucher R., Kuchel O., Nowaczynski W. Renin in hypertension: how important as a risk factor?. Can. Med. Assoc. J. 1975; 109: 475
   Web of Science ®Google Scholar
• Giese J. Renin, angiotensin and hypertensive vascular damage: a review. Am. J. Med. 1973; 55: 31511. Giese J. Renin, angiotensin and hypertensive vascular damage: a review. Am. J. Med. 1973; 55: 315
   PubMed Web of Science ®Google Scholar
• Grollman A., Harrison T. R., Williams J. R. Effect of various sterol derivatives on blood pressure in the rat. J. Pharmacol. Exp. Ther. 1940; 69: 14912. Grollman A., Harrison T. R., Williams J. R. Effect of various sterol derivatives on blood pressure in the rat. J. Pharmacol. Exp. Ther. 1940; 69: 149
   Google Scholar
• Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of radioimmunoassay of angiotensin I to the physiologic measurements of plasma renin activity in normal subjects. J. Clin. Endocrinol. Metab. 1969; 23: 134913. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of radioimmunoassay of angiotensin I to the physiologic measurements of plasma renin activity in normal subjects. J. Clin. Endocrinol. Metab. 1969; 23: 1349
   Google Scholar
• Hamilton M. Antihypertensive Therapy: Principles and Practice, an International Symposium, F. Gross. Springer Verlag, New York 1966; 19614. Hamilton M. Antihypertensive Therapy: Principles and Practice, an International Symposium, F. Gross. Springer Verlag, New York 1966; 196
   Google Scholar
• Hauger-Klevene J. H. Sal, stress e hipertensión arterial. Sem. Méd. 1977; 150: 38915. Hauger-Klevene J. H. Sal, stress e hipertensión arterial. Sem. Méd. 1977; 150: 389
   Google Scholar
• Hauger-Klevene J. H., Salischicker E. A. Cardiovascular complications in low renin hypertension. Medicina 1977; 37: 27916. Hauger-Klevene J. H., Salischicker E. A. Cardiovascular complications in low renin hypertension. Medicina 1977; 37: 279
   PubMed Web of Science ®Google Scholar
• Hodge J. V., Mcqueen E. G., Smirk H. Results of hypotensive therapy in essential hypertension. Br. Med. J. 1961; 1: 117. Hodge J. V., Mcqueen E. G., Smirk H. Results of hypotensive therapy in essential hypertension. Br. Med. J. 1961; 1: 1
   PubMedGoogle Scholar
• Hollander W. Hypertension, antihypertensive drugs and atherosclerosis. Circulation 1973; 48: 111218. Hollander W. Hypertension, antihypertensive drugs and atherosclerosis. Circulation 1973; 48: 1112
   PubMed Web of Science ®Google Scholar
• Kern D. C., Kramer N. J., Gomez-Sanchez C. The low renin state: definitions and implications. J. Clin. Invest. 1973; 52: 46a19. Kern D. C., Kramer N. J., Gomez-Sanchez C. The low renin state: definitions and implications. J. Clin. Invest. 1973; 52: 46a
   Google Scholar
• Lambert D. M. D. Beta-blockers and life expectancy in ischaemic heart disease. Lancet 1972; 1: 79320. Lambert D. M. D. Beta-blockers and life expectancy in ischaemic heart disease. Lancet 1972; 1: 793
   PubMed Web of Science ®Google Scholar
• Lambert D. M. D. Hypertension and myocardial infarction. Br. Med. J. 1974; 3: 68521. Lambert D. M. D. Hypertension and myocardial infarction. Br. Med. J. 1974; 3: 685
   PubMed Web of Science ®Google Scholar
• Lew E. A. High blood pressure, other risk factors and longevity: the insurance viewpoint. Am. J. Med. 1973; 55: 28122. Lew E. A. High blood pressure, other risk factors and longevity: the insurance viewpoint. Am. J. Med. 1973; 55: 281
   PubMed Web of Science ®Google Scholar
• De Leeuw P. W., Kho T. L., Falke H. E., BirkenhÄGer W. H., Wester A. Haemo-dynamic and endocrinological profile in essential hyperteasion. Acta Med. Scand. 1978; 47, Suppl. 62223. De Leeuw P. W., Kho T. L., Falke H. E., BirkenhÄGer W. H., Wester A. Haemo-dynamic and endocrinological profile in essential hyperteasion. Acta Med. Scand. 1978; 47, Suppl. 622
   Google Scholar
• Morgan T. O. Report on round table discussion on renin as a risk factor in hypertension. Clin. Sci. Mol. Med. 1975; 48: 123, Suppl. 224. Morgan T. O. Report on round table discussion on renin as a risk factor in hypertension. Clin. Sci. Mol. Med. 1975; 48: 123, Suppl. 2
   Google Scholar
• Mroczek W. J., Finnerty F. A., Catt K. J. Lack of association between plasma renin and history of heart attack or stroke in patients with essential hypertension. Lancet 1973; 2: 26425. Mroczek W. J., Finnerty F. A., Catt K. J. Lack of association between plasma renin and history of heart attack or stroke in patients with essential hypertension. Lancet 1973; 2: 264
   PubMedGoogle Scholar
• Sambhi M. P., Crane M. G., Genest J. Essential hypertension: new concepts about mechanisms. Ann. Int. Med. 1973; 49: 41126. Sambhi M. P., Crane M. G., Genest J. Essential hypertension: new concepts about mechanisms. Ann. Int. Med. 1973; 49: 411
   Google Scholar
• Stamler J., Berkson D. M., Lindberg H. A., Miller W., Hall Y. Racial patterns of coronary heart disease. Blood pressure, body weight and serum cholesterol in whites and negroes. Geriatrics 1961; 16: 38227. Stamler J., Berkson D. M., Lindberg H. A., Miller W., Hall Y. Racial patterns of coronary heart disease. Blood pressure, body weight and serum cholesterol in whites and negroes. Geriatrics 1961; 16: 382
   Web of Science ®Google Scholar
• Stroobandt R., Fagard R., Amery A. K. P. C. Are patients with essential hypertension and low renin protected against stroke and heart attack?. Am. Heart J. 1973; 86: 78128. Stroobandt R., Fagard R., Amery A. K. P. C. Are patients with essential hypertension and low renin protected against stroke and heart attack?. Am. Heart J. 1973; 86: 781
   PubMed Web of Science ®Google Scholar
• Swales J. D. The hunt for renal hypertension. Lancet 1976; 1: 57729. Swales J. D. The hunt for renal hypertension. Lancet 1976; 1: 577
   PubMed Web of Science ®Google Scholar
• Vedin A., Wilhemsson C., Werko L. Chronic alprcnolol treatment of patients with myocardial infarction after discharge from hospital. Effects on mortality and morbidity. Acta. Med. Scand. 1975; 575, Suppl. 130. Vedin A., Wilhemsson C., Werko L. Chronic alprcnolol treatment of patients with myocardial infarction after discharge from hospital. Effects on mortality and morbidity. Acta. Med. Scand. 1975; 575, Suppl. 1
   Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents Effect of treatment on morbidity and mortality in hypertension. I. Results in patients with diastolic blood pressures averaging 115 to 129 mmHg. J.A.M.A. 1967; 202: 102831. Veterans Administration Cooperative Study Group on Antihypertensive Agents Effect of treatment on morbidity and mortality in hypertension. I. Results in patients with diastolic blood pressures averaging 115 to 129 mmHg. J.A.M.A. 1967; 202: 1028
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents Effect of treatment on morbidity and mortality in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. J.A.M.A. 1970; 213: 114332. Veterans Administration Cooperative Study Group on Antihypertensive Agents Effect of treatment on morbidity and mortality in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. J.A.M.A. 1970; 213: 1143
   PubMed Web of Science ®Google Scholar
• Wilhelmsson C., Wilhelmsen L., Vedin J. A., Tibblin G., Werko L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet 1974; 2: 115733. Wilhelmsson C., Wilhelmsen L., Vedin J. A., Tibblin G., Werko L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet 1974; 2: 1157
   PubMed Web of Science ®Google Scholar
• Wolff F. W., Lindenman R. D. Effects of treatment in hypertension: results of a controlled study. J. Chronic Dis. 1966; 19: 22734. Wolff F. W., Lindenman R. D. Effects of treatment in hypertension: results of a controlled study. J. Chronic Dis. 1966; 19: 227
   PubMedGoogle Scholar